Mark Hyman FOUNDER, CLEVELAND CLINIC FUNCTIONAL MEDICINE, 16x NYT BESTSELLING AUTHOR, Rho Partner Rho's targeted nutrition and cellular support align perfectly with my functional medicine approach to support healthy aging from the inside out
Pancreatic concerns All GLP-1 receptor agonists carry theoretical concerns about pancreatitis and pancreatic cancer risk
This GHRH-analog-plus-ghrelin-mimetic synergy is well documented across the secretagogue literature and is the reason the two are combined in Durham Peptides' CJC-1295 (No DAC) + Ipamorelin Blend
Four Essential 30-Second Micro-Modules Expand Understanding The first micro-module compares semaglutide versus native GLP-1, highlighting 94% homology plus albumin binding against DPP-4 degradation with its two-minute half-life
This buffer protects against flight delays, lost luggage, damaged pens, or unexpected trip extensions
GHK-Cu requires understanding